TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 4, 2009, Pages 708-714

  Maisano, Francesco ^a   Kjærgård, Henrik K ^b   Bauernschmitt, Robert ^c   Pavie, Alain ^d   Rábago, Gregorio ^e   Laskar, Marc ^f   Marstein, Jens Pauli ^g   Falk, Volkmar ^h  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Rigshospitalet   (Denmark)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f DUPUYTREN UNIVERSITY HOSPITAL   (France)

^g Nycomed Denmark   (Denmark)

^h UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Cardiovascular surgical procedures; Haemostasis; TachoSil

Indexed keywords

FIBRINOGEN; HEMOSTATIC AGENT; THROMBIN;

ADULT; AGED; ARTICLE; ASCENDING AORTA; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL EQUIPMENT; SURGICAL SPONGE; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGICAL PROCEDURES; COATED MATERIALS, BIOCOMPATIBLE; DRUG COMBINATIONS; FEMALE; FIBRINOGEN; HEMOSTASIS, SURGICAL; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; THROMBIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69849115358     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.04.057     Document Type: Article

References (24)

1. Harmon D.E. Cost/benefit analysis of pharmacologic hemostasis. Ann Thorac Surg 61 2 Suppl. (1996) S21-S25
2. Shore-Lesserson L., Reich D.L., Silvay G., and Griepp R.B. Hemostasis in aortic and cardiothoracic surgery. J Card Surg 12 2 Suppl. (1997) 232-237
3. Hartmann M., Sucker C., Boehm O., Koch A., Loer S., and Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 20 (2006) 230-241
4. Jámbor C., Bremerich D., Moritz A., Seifried E., and Zwissler B. Management of hemostasis disorders after extracorporeal circulation: a clinical therapy algorithm. Anaesthesist 57 (2008) 374-381
5. Kjaergard H.K., and Fairbrother J.E. Controlled clinical studies of fibrin sealant in cardiothoracic surgery - a review. Eur J Cardiothorac Surg 10 (1996) 727-733
6. Oz M.C., Cosgrove III D.M., Badduke B.R., Hill J.D., Flannery M.R., Palumbo R., Topic N., and The Fusion Matrix Study Group. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69 (2000) 1376-1382
7. Chapman W.C., and CoStasis Multi-center Collaborative Writing Committee. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial. Surgery 129 (2001) 445-450
8. Lowe J., Luber J., Levitsky S., Hantak E., Montgomery J., Schiestl N., Schofield N., Marra S., and TISSEEL Clinical Study Group. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. J Cardiovasc Surg (Torino) 48 (2007) 323-331
9. Lang G., Csekeö A., Stamatis G., Lampl L., Hagman L., Marta G.M., Mueller M.R., and Klepetko W. Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy. Eur J Cardiothorac Surg 25 (2004) 160-166
10. Anegg U., Lindenmann J., Matzi V., Smolle J., Maier A., and Smolle-Jüttner F. Efficiency of fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial. Eur J Cardiothorac Surg 31 (2007) 198-202
11. Siemer S., Lahme S., Altziebler S., Machtens S., Strohmaier W., Wechsel H.W., Goebell P., Schmeller N., Oberneder R., Stolzenburg J.U., Becker H., Lüftenegger W., Tetens V., and Van Poppel H. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. Eur Urol 52 (2007) 1156-1163
12. Frilling A., Stavrou G.A., Mischinger H.J., de Hemptinne B., Rokkjaer M., Klempnauer J., Thörne A., Gloor B., Beckebaum S., Ghaffar M.F., and Broelsch C.E. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 390 (2005) 114-120
13. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
14. Despotis G.J., Avidan M.S., and Hogue Jr. C.W. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72 (2001) S1821-S1831
15. Weaver F.A., Hood D.B., Zatina M., Messina L., and Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16 (2002) 286-293
16. Rousou J., Levitsky S., Gonzalez-Lavin L., Cosgrove D., Magilligan D., Weldon C., Hiebert C., Hess P., Joyce L., and Bergsland J. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 97 (1989) 194-203
17. Hanks J.B., Kjaergard H.K., and Hollingsbee D.A. A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 35 (2003) 439-444
18. Schiele U., Kuntz G., and Riegler A. Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue. Clin Mater 9 (1992) 169-177
19. Carbon R.T. Evaluation of biodegradable fleece-bound sealing: history, material science, and clinical application in tissue engineering and biodegradable equivalents. In: Lewandrowski K.-U., Wise D.L., Trantolo D.J., Gresser J.D., Yaszemski M.J., and Altobelli D.E. (Eds). Scientific and clinical applications (2002), Marcel Dekker 587-650
20. Erdogan D., de Graaf W., and van Gulik T.M. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res 41 (2008) 298-302
21. Czerny M., Verrel F., Weber H., Müller N., Kircheis L., Lang W., Steckmeier B., and Trubel W. Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg (Torino) 41 (2000) 553-557
22. Joseph T., Adeosun A., Paes T., and Bahal V. Randomised controlled trial to evaluate the efficacy of TachoComb H patches in controlling PTFE suture-hole bleeding. Eur J Vasc Endovasc Surg 27 (2004) 549-552
23. Shimamoto T., Marui A., Nishina T., Saji Y., and Komeda M. The TachoSil-Pledget stitch: towards eradication of suture hole bleeding. Ann Thorac Surg 86 (2008) 2002-2004
24. Unlü Y., Vural U., Koçak H., Ceviz M., Becit N., and Akbulut O. Comparison of the topical haemostatic agents for the prevention of suture hole bleeding. An experimental study. Eur J Vasc Endovasc Surg 23 (2002) 441-444